Tag: foundry row
-

Ridgeline Therapeutics Raises Its Own Funding Round Amid Talent Competition With Kestrel
Ridgeline Therapeutics has closed a $38 million funding round it says is aimed at competing with rival Kestrel Biologics for Bellwater’s limited pool of biotech talent.
-

City Weighs Height Limits for Next Wave of Foundry Row Towers
A proposal to cap new Foundry Row towers at 12 stories has split biotech employers seeking room to grow from tenant advocates who say unchecked height will accelerate displacement, with a council vote expected in coming weeks.
-

New Foundry Row Parking Garage Tied to Biotech Campus Expansion
The city and Kestrel Biologics will split the cost of a 600-space Foundry Row parking garage tied to the biotech firm’s hiring surge, a deal some residents say undercuts the neighborhood’s new transit line.
-

Lowertown Tenant Alliance Files Second Suit, This Time Against a Different Developer
The Lowertown Tenant Alliance has sued a second Foundry Row developer over an alleged affordable-unit shortfall, prompting city officials to consider a citywide compliance audit of redevelopment agreements.
-

New Kincaid Spinout Closes Seed Funding Round
Halcyon Biotherapeutics, Kincaid University’s newest biotech spinout, has closed an $8 million seed funding round to fund its first 18 months of preclinical research.
-

Foundry Row Employers Formalize Addiction Referral Partnership With Wayfinder
Three Foundry Row employers have formalized a referral partnership with Wayfinder Recovery Services, giving managers a direct path to get employees into treatment rather than losing them.
-

Report Finds Foundry Row Biotech Cluster Has Doubled Jobs in Five Years
A new city-commissioned report finds Foundry Row’s biotech cluster has roughly doubled its workforce in five years, though hiring growth has slowed amid a persistent shortage of trained technicians.
-

Kincaid’s Technology-Transfer Office Announces a Second Biotech Spinout
Kincaid University’s technology-transfer office has announced Halcyon Biotherapeutics, its second biotech spinout, built around a faculty lab’s autoimmune-disease research.
-

Another Foundry Row Warehouse Set for Loft Conversion
Redline Property Group wants to convert a former Anvil Street casting plant into 86 Foundry Row apartments, pledging a bigger affordable-unit share than the one now in dispute at the nearby Foundry District Lofts.
-

City Studies Rezoning Mill Street Corridor Beyond the Lofts Site
Bellwater’s planning department has launched a corridor-wide study of Mill Street, aiming to set consistent zoning and affordable-housing rules after lawsuits exposed gaps in project-by-project agreements.